What Happened
- Following the US Supreme Court's invalidation of IEEPA-based tariffs, the Trump administration imposed a 10% global import surcharge under Section 122 of the Trade Act of 1974, effective from February 24, 2026.
- India, along with all other US trading partners, is now subject to this 10% tariff for a statutory maximum period of 150 days.
- The Indian government stated it is studying the implications of the new tariff for Indian exporters and will evaluate its options, including WTO recourse.
- The 10% rate applies uniformly to all countries because Section 122 prohibits country-specific differentiation — this means India receives the same treatment as China, Vietnam, and even US allies.
- India had recently finalised an interim bilateral trade deal with the US (18% reciprocal tariff on select goods), and the new 10% global surcharge creates uncertainty about how the two tariff regimes interact.
Static Topic Bridges
India's Export Exposure and Balance of Payments Dynamics
India's current account — the broadest measure of its trade and income flows with the rest of the world — typically runs a deficit, financed by surplus in the capital and financial account (FDI, portfolio flows, remittances). A significant rise in US tariffs on Indian goods affects India's current account by reducing export earnings. India's goods exports to the US were approximately $77 billion in 2024, making the US India's largest goods export destination. Key exposed sectors include: pharmaceuticals (generic drugs), gems and diamonds, textiles, engineering goods, leather, and chemicals.
- India's current account deficit: approximately 1-2% of GDP in recent years
- India's goods exports to US: ~$77 billion (2024); US is India's largest single-country export destination
- Remittances from the US: India received approximately $32 billion from North America in 2024
- FDI from the US: Over $60 billion cumulative; a tariff-induced slowdown in trade could affect investment too
- Pharmaceutical exports: India supplies ~40% of US generic drug needs; zero tariff retained under interim deal but 10% surcharge may override
Connection to this news: The 10% surcharge directly reduces the price competitiveness of Indian goods in the US market, widening India's effective tariff burden — particularly for textiles and engineering goods that already face competition from countries with lower production costs.
Section 122 Tariff: Legal Architecture and Constraints
Section 122 of the Trade Act of 1974 provides the President limited authority to impose temporary import surcharges of up to 15% for up to 150 days to address balance-of-payments deficits or imminent dollar depreciation. The statute requires that the surcharge be applied uniformly across all imports — no country-specific rates are permitted. This uniform requirement sharply limits the executive's ability to use tariffs as a bilateral negotiating tool, unlike IEEPA-based tariffs which allowed differentiated country-level rates. Congress enacted Section 122 after Nixon's 1971 10% import surcharge during the breakdown of the Bretton Woods fixed-exchange-rate system.
- Rate cap: 15% ad valorem
- Duration cap: 150 days (approximately 5 months) — extendable only by Congress
- Uniformity requirement: Same rate must apply to all countries — cannot exempt allies or punish specific adversaries
- Legal trigger: "Large and serious" US balance-of-payments deficit or "imminent and significant" dollar depreciation
- Critics note: US does not have a balance-of-payments deficit in the technical sense — it has a current account deficit but a capital account surplus; the two net out
Connection to this news: India faces 10% for 150 days under this uniform authority — unlike earlier IEEPA tariffs that applied differentiated rates. This means the previously negotiated 18% bilateral rate and the 10% global rate may interact in complex ways that need legal and trade policy clarification.
India's Trade Diversification Strategy
Faced with the volatility of the US market, India's trade policy has increasingly emphasised geographic diversification of export destinations. India has concluded or is negotiating Free Trade Agreements with the UAE (CEPA, 2022), UK, EU, Australia (interim ECTA, 2022), GCC, Canada, and Israel. The India-UAE CEPA — which came into force in May 2022 — was India's first FTA with a major economy in a decade and served as a template for subsequent agreements. The "China Plus One" strategy pursued by global manufacturers has also benefited India in sectors like electronics and textiles.
- India-UAE CEPA: signed February 2022, in force May 2022 — eliminates/reduces tariffs on 80% of goods
- India-Australia ECTA: signed April 2022, in force December 2022 — interim agreement, broader CECA under negotiation
- India-UK FTA: under negotiation since January 2022; paused and resumed multiple times
- India-EU FTA: relaunched in 2022 after decade-long break; covers trade in goods, services, and investment
- India-GCC FTA: Terms of Reference signed February 5, 2026 — formal negotiations launched
- "China Plus One": manufacturing shift benefiting India especially in electronics (Apple supply chain) and pharmaceuticals
Connection to this news: The US tariff uncertainty reinforces India's incentive to complete pending FTA negotiations with the EU, UK, and GCC — reducing dependence on any single large trading partner. UPSC frequently tests India's bilateral trade architecture in GS2 and GS3.
Key Facts & Data
- Section 122 global surcharge rate: 10% (raised to 15% on Day 2)
- Duration: 150 days (effective February 24, 2026)
- India's goods exports to US: ~$77 billion (2024)
- India's US pharmaceutical export share: ~40% of US generic drug market
- India-UAE CEPA in force: May 2022
- India-Australia ECTA in force: December 2022
- Section 122 enacted: Trade Act of 1974 (19 USC 2132)
- Nixon's 1971 surcharge (precursor): 10% import surcharge, Bretton Woods collapse
- 150-day clock started: February 24, 2026